We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The use of social media to help promote drugs or medical devices is hugely attractive to savvy companies. Social media is ubiquitous in the daily lives of many consumers, including patients, healthcare providers and disease awareness groups. And the ability to share information directly and interactively with these audiences is very attractive to drug and device marketing teams. Read More
A comprehensive readiness plan for an FDA inspection includes thorough knowledge of your document archiving and transfer procedures, according to an FDA inspections expert speaking at the WCG FDAnews Annual FDA Inspections Summit in Washington, D.C., Nov. 16-18. Read More
A retrospective analysis of Masimo SET pulse oximetry readings in healthy Black and White volunteers showed no clinically significant bias due to skin pigmentation, the company said, citing a study reported in the Journal of Clinical Monitoring and Computing. Read More
SpaceX’s upcoming resupply mission to the International Space Station (ISS) National Laboratory will test the viability of a new remote-controlled drug delivery implant to provide extended, adjustable medication from afar. Read More
Philips Respironics has informed the FDA of two new potential issues with its reworked Trilogy ventilators that were part of a June 2021 recall. Read More
California’s HeartVista has teamed with Germany-based Siemens Healthineers to co-market an automated cardiac magnetic resonance (CMR) imaging exam platform that takes up less scanner time and requires no additional training for technicians. Read More
The integrity of manufacturers’ data is a major focus of FDA inspections and the agency’s investigators will go to great lengths to uncover problems, three former FDA inspection officials told attendees at the WCG FDAnews 17th Annual FDA Inspections Summit in Washington, D.C. last week. Read More